Cyclin C surprises in tumour suppression
Marianna Trakala1, Marcos Malumbres1
1Centro Nacional de Investigaciones Oncológicas (CNIO), Melchor Fernández Almagro 3, E-28029 Madrid, Spain.
Nature Cell Biology
|November 1, 2014
Summary
Cyclin C and its associated kinases Cdk3, Cdk8, and Cdk19 act as tumor suppressors in blood cancers. They inhibit the Notch1 pathway, a key regulator in cell division and cancer development.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Cyclins and cyclin-dependent kinases (Cdks) are crucial regulators of cell division.
- The specific roles of many cyclins and Cdks in physiological processes are not fully understood.
- Hematopoietic malignancies involve dysregulation of cell division.
Purpose of the Study:
- To investigate the physiological role of Cyclin C and its associated kinases (Cdk3, Cdk8, Cdk19).
- To determine the involvement of these regulators in controlling cell division within the context of hematopoietic malignancies.
- To elucidate the mechanism by which Cyclin C and its associated kinases may act as tumor suppressors.
Main Methods:
- Utilized molecular biology techniques to study Cyclin C, Cdk3, Cdk8, and Cdk19.
- Investigated the impact of these proteins on cell division control.
- Analyzed the interaction between these regulators and the Notch1 pathway in cancer models.
Main Results:
- Cyclin C, Cdk3, Cdk8, and Cdk19 were identified as key regulators in cell division.
- These kinases were demonstrated to function as tumor suppressors in hematopoietic malignancies.
- Inhibition of the Notch1 pathway by Cyclin C and its associated kinases was confirmed.
Conclusions:
- Cyclin C and its associated kinases (Cdk3, Cdk8, Cdk19) play a significant role in suppressing tumor formation in blood cancers.
- Targeting the Notch1 pathway through these regulators offers a potential therapeutic strategy for hematopoietic malignancies.
Related Concept Videos
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
02:34Inhibition of CDK Activity
4.3K
4.3K
01:23Negative Regulator Molecules
32.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
02:23Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
02:39Positive Regulator Molecules
5.3K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K
01:45Positive Regulator Molecules
100.8K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
100.8K